CSPC PHARMACEUT.GR. ADR4 (CVGU) — Financial Flexibility Index
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Financial Flexibility Index of 0.67x as of December 2025. Free cash flow of €8.11 Billion (operating CF €5.83 Billion minus capex €2.28 Billion) represents 1% of total liabilities (€12.15 Billion). Check CSPC PHARMACEUT.GR. ADR4 liquidity resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CSPC PHARMACEUT.GR. ADR4 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. See CSPC PHARMACEUT.GR. ADR4 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Year-by-year free cash flow to debt coverage for CSPC PHARMACEUT.GR. ADR4. For the full company profile including market capitalisation, see CSPC PHARMACEUT.GR. ADR4 market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | €8.11 Billion | €5.83 Billion | €12.15 Billion | ▼ -2.6% |
| 2024 | 0.69x | €7.21 Billion | €4.53 Billion | €10.52 Billion | ▲ +27.2% |
| 2023 | 0.54x | €6.07 Billion | €4.18 Billion | €11.26 Billion | ▼ -47.3% |
| 2022 | 1.02x | €10.35 Billion | €7.63 Billion | €10.13 Billion | ▲ +26.5% |
| 2021 | 0.81x | €6.40 Billion | €4.64 Billion | €7.91 Billion | — |